Sundrug Co.,Ltd. (TYO:9989)

Sundrug Income Statement

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Revenue	789,399	751,777	690,462	648,734	634,310	617,769
Revenue Growth (YoY)	7.13%	8.88%	6.43%	2.27%	2.68%	5.05%
Cost of Revenue	589,152	562,457	518,516	492,228	475,760	463,150
Gross Profit	200,247	189,320	171,946	156,506	158,550	154,619
Selling, General & Admin	142,617	133,294	134,492	122,454	120,879	117,996
Other Operating Expenses	-	-	-	-	325	17
Operating Expenses	157,646	148,323	134,495	122,454	121,204	118,013
Operating Income	42,601	40,997	37,451	34,052	37,346	36,606
Interest Expense	-113	-32	-36	-9	-6	-8
Interest & Investment Income	130	127	125	128	130	136
Other Non Operating Income (Expenses)	863	636	594	563	758	425
EBT Excluding Unusual Items	42,302	41,728	38,134	34,734	38,228	37,159
Gain (Loss) on Sale of Assets	15	21	144	232	119	-
Asset Writedown	-1,024	-856	-864	-282	-375	-2,347
Other Unusual Items	634	367	296	-10	-784	-164
Pretax Income	41,927	41,260	37,710	34,674	37,188	34,648
Income Tax Expense	11,752	12,134	12,007	10,821	11,859	10,956
Net Income	30,175	29,126	25,703	23,853	25,329	23,692
Net Income to Common	30,175	29,126	25,703	23,853	25,329	23,692
Net Income Growth	7.31%	13.32%	7.76%	-5.83%	6.91%	-1.01%
Shares Outstanding (Basic)	117	117	117	117	117	117
Shares Outstanding (Diluted)	117	117	117	117	117	117
Shares Change (YoY)	0.02%	0.01%	0.01%	0.00%	0.02%	0.01%
EPS (Basic)	258.00	249.06	219.83	204.02	216.67	202.67
EPS (Diluted)	258.00	249.06	219.82	204.01	216.63	202.67
EPS Growth	7.29%	13.30%	7.75%	-5.83%	6.89%	-1.02%
Free Cash Flow	-	4,762	12,591	12,857	15,944	22,026
Free Cash Flow Per Share	-	40.72	107.68	109.96	136.36	188.41
Dividend Per Share	57.000	114.000	100.000	71.000	70.000	68.000
Dividend Growth	-46.73%	14.00%	40.85%	1.43%	2.94%	3.03%
Gross Margin	25.37%	25.18%	24.90%	24.12%	25.00%	25.03%
Operating Margin	5.40%	5.45%	5.42%	5.25%	5.89%	5.93%
Profit Margin	3.82%	3.87%	3.72%	3.68%	3.99%	3.84%
Free Cash Flow Margin	-	0.63%	1.82%	1.98%	2.51%	3.57%
EBITDA	60,022	56,124	49,519	44,261	46,009	44,965
EBITDA Margin	7.60%	7.47%	7.17%	6.82%	7.25%	7.28%
D&A For EBITDA	17,421	15,127	12,068	10,209	8,663	8,359
EBIT	42,601	40,997	37,451	34,052	37,346	36,606
EBIT Margin	5.40%	5.45%	5.42%	5.25%	5.89%	5.93%
Effective Tax Rate	28.03%	29.41%	31.84%	31.21%	31.89%	31.62%

Source: S&P Capital IQ. Standard template. Financial Sources.